These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34623184)

  • 41. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity.
    Milano G; Biemmi V; Lazzarini E; Balbi C; Ciullo A; Bolis S; Ameri P; Di Silvestre D; Mauri P; Barile L; Vassalli G
    Cardiovasc Res; 2020 Feb; 116(2):383-392. PubMed ID: 31098627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair.
    Huang CK; Dai D; Xie H; Zhu Z; Hu J; Su M; Liu M; Lu L; Shen W; Ning G; Wang J; Zhang R; Yan X
    Circ Res; 2020 Sep; 127(8):953-973. PubMed ID: 32600176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Total flavonoids from Anchusa italica Retz. Improve cardiac function and attenuate cardiac remodeling post myocardial infarction in mice.
    Wang S; Zhao Y; Song J; Wang R; Gao L; Zhang L; Fang L; Lu Y; Du G
    J Ethnopharmacol; 2020 Jul; 257():112887. PubMed ID: 32315737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
    Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
    Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair.
    Zhang Z; Yang J; Yan W; Li Y; Shen Z; Asahara T
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-19a-3p containing exosomes improve function of ischaemic myocardium upon shock wave therapy.
    Gollmann-Tepeköylü C; Pölzl L; Graber M; Hirsch J; Nägele F; Lobenwein D; Hess MW; Blumer MJ; Kirchmair E; Zipperle J; Hromada C; Mühleder S; Hackl H; Hermann M; Al Khamisi H; Förster M; Lichtenauer M; Mittermayr R; Paulus P; Fritsch H; Bonaros N; Kirchmair R; Sluijter JPG; Davidson S; Grimm M; Holfeld J
    Cardiovasc Res; 2020 May; 116(6):1226-1236. PubMed ID: 31410448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Macrophages promote the transition from myocardial ischemia reperfusion injury to cardiac fibrosis in mice through GMCSF/CCL2/CCR2 and phenotype switching.
    Shen SC; Xu J; Cheng C; Xiang XJ; Hong BY; Zhang M; Gong C; Ma LK
    Acta Pharmacol Sin; 2024 May; 45(5):959-974. PubMed ID: 38225394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
    Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
    Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective role of cardiac CFTR activation upon early reperfusion against myocardial infarction.
    Uramoto H; Okada T; Okada Y
    Cell Physiol Biochem; 2012; 30(4):1023-38. PubMed ID: 23221371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myeloid interleukin-4 receptor α is essential in postmyocardial infarction healing by regulating inflammation and fibrotic remodeling.
    Song J; Frieler RA; Whitesall SE; Chung Y; Vigil TM; Muir LA; Ma J; Brombacher F; Goonewardena SN; Lumeng CN; Goldstein DR; Mortensen RM
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H323-H337. PubMed ID: 33164548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
    Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC
    Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective role of Gremlin-1 in myocardial function.
    Müller II; Schneider M; Müller KAL; Lunov O; Borst O; Simmet T; Gawaz M
    Eur J Clin Invest; 2021 Jul; 51(7):e13539. PubMed ID: 33729579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exosomes derived from human placental mesenchymal stem cells ameliorate myocardial infarction via anti-inflammation and restoring gut dysbiosis.
    Yang L; Wang T; Zhang X; Zhang H; Yan N; Zhang G; Yan R; Li Y; Yu J; He J; Jia S; Wang H
    BMC Cardiovasc Disord; 2022 Feb; 22(1):61. PubMed ID: 35172728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration.
    Huang C; Liu Y; Beenken A; Jiang L; Gao X; Huang Z; Hsu A; Gross GJ; Wang YG; Mohammadi M; Schultz JEJ
    Cardiovasc Res; 2017 Nov; 113(13):1585-1602. PubMed ID: 29016740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. KIAA1199/CEMIP knockdown attenuates cardiac remodeling post myocardial infarction by activating TSP4 pathway in mice.
    Zha Y; Luo X; Ge Z; Zhang J; Li Y; Zhang S
    Biochim Biophys Acta Mol Basis Dis; 2024 Dec; 1870(8):167473. PubMed ID: 39173890
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous miR-144 reduces left ventricular remodeling after myocardial infarction.
    Li J; Cai SX; He Q; Zhang H; Friedberg D; Wang F; Redington AN
    Basic Res Cardiol; 2018 Aug; 113(5):36. PubMed ID: 30084039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sodium 4-Phenylbutyrate Attenuates Myocardial Reperfusion Injury by Reducing the Unfolded Protein Response.
    Takatori O; Usui S; Okajima M; Kaneko S; Ootsuji H; Takashima SI; Kobayashi D; Murai H; Furusho H; Takamura M
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):283-292. PubMed ID: 27909014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TRPV4 deletion protects heart from myocardial infarction-induced adverse remodeling via modulation of cardiac fibroblast differentiation.
    Adapala RK; Kanugula AK; Paruchuri S; Chilian WM; Thodeti CK
    Basic Res Cardiol; 2020 Jan; 115(2):14. PubMed ID: 31925567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
    Santos-Gallego CG; Vahl TP; Goliasch G; Picatoste B; Arias T; Ishikawa K; Njerve IU; Sanz J; Narula J; Sengupta PP; Hajjar RJ; Fuster V; Badimon JJ
    Circulation; 2016 Mar; 133(10):954-66. PubMed ID: 26826180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486-5p targeting the PTEN/PI3K/AKT signaling pathway.
    Sun XH; Wang X; Zhang Y; Hui J
    Thromb Res; 2019 May; 177():23-32. PubMed ID: 30844685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.